Slide 1: Momentum and Growth: 2023 Full-Year Results
Momentum and Growth 8 March 2024 2023 Full - Year Results
Slide 2: Disclaimer
Disclaimer 2023 Full - Year Results 2 This presentation contains forward - looking statements concerning the financial condition, results of operations and businesses of the Group . Although the Group believes that the expectations reflected in such forward - looking statements are reasonable, these
Slide 3: Variable Macro-Economic Backdrop
Value of Live in a digital world Variable Macro - Economic Backdrop 2023 Full - Year Results 3 Significant variance in macro - economic trends across all five regions Carbon reduction Half the world is voting Geo - political uncertainty Economic diversification Investment in R&D and innovation Heigh
Slide 4: Knowledge & information economy
Knowledge & information economy 4 Specialist Knowledge Specialist Brands Advanced Learning Specialist Market Research Pay - to - Publish On - Demand Access First Party Data Artificial Intelligence Live Experiences Pay - to - Read Audience Development Digital Demand Generation Peer Reviewed Research
Slide 5: The Value of Specialisation
The Value of Specialisation 2023 Full - Year Results 5 Championing the specialist in B2B Markets, Academic Markets and Digital Services The Power of Live First party data Subject specialties International communities Specialist connections Niche markets Specialist Knowledge B2B audiences Lead genera
Slide 6: Major Brands in Major Markets
Major Brands in Major Markets 2023 Full - Year Results 6 Healthcare & Pharmaceuticals 170k+ 30+ 2,000+ Attendees Age Exhibitors Humanities & Social Sciences 170k+ 170+ 150+ Reference Titles Age Subject categories Health & Nutrition 80k+ 35+ 3,000+ Attendees Age Exhibitors Cybersecurity 60k+ 25+ 400+
Slide 7: 2023 Highlights
2023 Highlights 2023 Full - Year Results 7 A standout performance in 2023 with continuing momentum and growth in 2024 Strength Increasing Growing Higher Strong Underlying growth: Revenue 30%+, Adjusted Operating Profit c.60%, Free Cash Flow c.50% Operating Margin: Significant increase to 26.8% Adjus
Slide 8: 2024 Momentum and Growth
i informa 2024 Momentum ’ and Growth A
Slide 9: 2024 Growth Drivers
2024 Growth Drivers 2023 Full - Year Results 9 Growth and momentum in 2024 High single digit Revenue / Double Digit Operating Profit International Expansion Strength in the US and rapidly expanding economies in IMEA, ASEAN and China High growth B2B Markets Pharma, Healthcare, Technology, Health & Nu
Slide 10: 2024 Revenue Forward Visibility
2023 Full - Year Results 10 2024 Revenue £500m+ to date with a further £1bn+ booked, committed or visible 2024 Forward Visibility c70% 75 %+ £500m+ Revenue to date Subscription Revenues Live & On - Demand Visibility Informa Group Revenue traded to date 2024 2024 Full Year Subscription revenue booked
Slide 11: Strong Financial Performance & Effective Capital Management
Strong Financial Performance & Effective Capital Management Gareth Wright Group Finance Director 2023 Full - Year Results
Slide 12: Accelerating Growth
2023 Full - Year Results: Accelerating Growth 2023 Full - Year Results Shareholder returns in 2023 Revenue £3,190m + 41 % Y oY (2022: £2,262m) Underlying Revenue Growth 30.4% (2022: 31.4%) Adjusted Operating Profit £854m +72% Y oY (2022: £496m) Adjusted Diluted EPS 45.3p +86% Y oY (2022: 24.4p) Divi
Slide 13: Momentum and Growth through 2023
Momentum and Growth through 2023 13 2023 Underlying Growth: Revenue 30%+, Adjusted Operating Profit c.60% 2023 Full - Year Results 2022 FY Results 9 March 2023 2023 AGM 15 June 2023 2023 HY Results 27 July 2023 2023 10 - Month 14 November 2023 Pre - Close Update 10 January 2024 2023 FY Results 8 Mar
Slide 14: Accelerating Growth & Financial Delivery
Accelerating Growth & Financial Delivery 2023 Full - Year Results 14 Continuing Operations: 2023 £m 2022 £m Revenue 3,189.6 2,262.4 Adjusted Operating Profit 853.8 496.3 Adjusted Operating Margin 26.8% 21.9% Net adjusted finance costs (19.2) (45.3) Adjusted Profit before tax 834.6 451.0 Adjusting it
Slide 15: Strong underlying growth in all Divisions
15 Informa Markets… Strong Growth • Full return of Live and On - Demand B2B Events in all regions and markets • Strong operating leverage Informa Connect… Continuing Growth • Strong demand for content - rich live experiences • Strong operating leverage and improving mix Tarsus… Combination and Growt
Slide 16: Accelerating Revenue and Profit Growth
Accelerating Revenue and Profit Growth 2023 Full - Year Results 16 2023 Revenue Growth (%) * 2023 Adjusted Operating Profit Growth (%) * 30.4 - 1.3 13.3 - 1.4 * All numbers are based on Continuing Operations 41.0% Reported Growth 72.0% Reported Growth
Slide 17: Strong Operating Leverage
Strong Operating Leverage 2023 Full - Year Results 17 Strong revenue growth and efficient cost management delivering higher operating margins Improving Operating Margin • Strong Underlying Revenue Growth • Strong operating leverage • Efficient cost management • Additions of Tarsus and Winsight • Mar
Slide 18: Balance Sheet Strength and Flexibility
0 200 400 600 800 1000 1200 1400 1600 2023 2024 2025 2026 2027 2028 Balance Sheet Strength and Flexibility 18 Debt maturities at 31 December 2023 (£m) Covenant - free, fixed rate debt with long - term maturities and substantial liquidity Average debt maturity 2.7 years Year - end pension surplus ove
Slide 19: 2024 Momentum and Growth
i informa 2024 Momentum ’ and Growth A
Slide 20: 2024 Momentum and Growth…Shareholder Returns
2024 Momentum and Growth…Shareholder Returns 2023 Full - Year Results 20 Operating Cash Flow Conversion 90%+…2024 Free Cash Flow £720m+ Organic Investment Consistent Capex at 3 - 4% of revenue (£100m - £140m p.a.) Share Buybacks Annual share buybacks, flexed with inorganic investment (Minimum £340m+
Slide 21: 2024 Market Guidance: Further Strong Growth
2024 Market Guidance: Further Strong Growth 2023 Full - Year Results 21 Further strong underlying growth in Revenue and Adjusted Operating Profit Pre - Close Update 10 January 2024 2023 Full Year Results 8 March 2024 Market Guidance updated to reflect strong start to the year, including particularly
Slide 22: Momentum and Growth: Stephen A. Carter
Momentum and Growth Stephen A. Carter Group Chief Executive 2023 Full Year Results
Slide 23: The Power of Live
The Power of Live 23 The multiplier effect Promotion & Awareness Strategic value Convening power Scarcity value Discovery Economic growth Innovation accelerator The strategic value of MICE (Meetings, Incentives, Conferences, Expos) Host city Unique connections Market accelerator International invest
Slide 24: Major B2B Brands in Major Markets
Power Brands $10m - $30m 40 Brands National Brands $1m - $3m 200+ Brands Major B2B Brands in Major Markets 2023 Full - Year Results 24 Leading Brands in growing B2B markets Marquee Brands $30m+ 20 Brands CPhI (Pharma) Natural Products (Health & Nutrition) Black Hat ( CyberSecurity ) SuperReturn (Pri
Slide 25: Five Geographic B2B Growth Pillars
Momentum & Growth…Five Geographic B2B Growth Pillars 2023 Full - Year Results c.20 new launches in rapidly growing markets in 2024 $1.2bn+ Revenues 10%+ Growth 5 2024 Launches Americas $125m+ Revenues 10%+ Growth 4 2024 Launches ASEAN $300m+ Revenues 20%+ Growth 5 2024 Launches IMEA $450m+ Revenues
Slide 26: IMEA a Growing Geographic B2B Pillar
Momentum & Growth…IMEA a Growing Geographic B2B Pillar 2023 Full - Year Results 26 $300m+ Revenues in IMEA, growing 20%+ United Arab Emirates Kingdom of Saudi Arabia Kingdom of Bahrain Egypt Türkiye India Major brands in IMEA Rapidly growing economies with strong demand for specialist knowledge, B2B
Slide 27: Marquee Brands: Healthcare & Pharmaceuticals
2023 Full - Year Results 4,300 Exhibitors 130k Professionals £2.5bn Transactions 75+ Exhibiting Countries $90m+ 20%+ 2024 Revenue YoY Growth Marquee Brands = Power, Impact, Value Healthcare & Pharmaceuticals
Slide 28: Marquee Brands: Technology Innovation
2023 Full - Year Results Marquee Brands = Power, Impact, Value Technology Innovation 1,800 Exhibitors 170k Professionals $4.9tn Investors AUM 50+ Exhibiting Countries $70m+ 30%+ 2024 Revenue YoY Growth
Slide 29: Momentum & Growth…First Party Data
Momentum & Growth…First Party Data 2023 Full - Year Results 29 • Lead generation platform for sponsors and exhibitors • Powered by IIRIS first party data (enrichment, intent, segmentation) • Real - time access, single view of leads across multiple Informa brands • Launch and track marketing campaign
Slide 30: The Power and Potential of Artificial Intelligence at Informa
The Power and Potential of Artificial Intelligence at Informa 30 AI already embedded within portfolio, with opportunity for expansion 2023 Full Year Results AI already deployed throughout Informa in a variety of products and services Existing use cases largely delivering improved productivity and co
Slide 31: Live & On-Demand Events, Powered by AI
2023 Full - Year Results 31 Live & On - Demand Events, Powered by AI
Slide 32: Momentum and Growth…New TechTarget
Momentum and Growth…New TechTarget 2023 Full - Year Results 32 Prospective combination on track to complete in second half of 2024 * ✓ Proposed combination of Informa Tech’s digital businesses with US - listed TechTarget ✓ Informa to contribute Informa Tech’s digital businesses and c.$350m cash for
Slide 33: Increased scale and depth at New Informa Connect
Increased scale and depth at New Informa Connect 2023 Full - Year Results 33 c.£900m Revenue 6 Core verticals 100+ £1m+ Brands 70% | 20% | 10% Events|Subscriptions|Other £580m Revenue 5 Core verticals 75 + £1m+ Brands 60% | 25% | 15% Events|Subscriptions|Other £275m Revenue 2 Core verticals 40+ £1m+
Slide 34: New Informa Connect…Major Brands
New Informa Connect…Major Brands 2023 Full - Year Results 34 Biotech & Life Sciences 9k+ 15+ 290+ Attendees Age Exhibitors Foodservice 60k+ 100+ 1,800+ Attendees Age Exhibitors Finance 9k+ 25+ 400+ Attendees Age Exhibitors Cybersecurity 60k+ 25+ 600+ Attendees Age Exhibitors Anti - Ageing & Aestheti
Slide 35: Growing portfolio of Academic Services
Growing portfolio of Academic Services 2023 Full - Year Results 35 Journal Subscriptions Institutional eBooks Reference Titles Database & Access Licensing & Meta Data Advertising Reprints & Content Services eBook Retail & eCommerce Archives & Digital Resources Read & Publish Agreements Pure Open Acc
Slide 36: Improving Underlying Growth
Momentum & Growth…Improving Underlying Growth 2023 Full - Year Results 36 GAP2 investment delivering higher levels of underlying growth 90%+ Subscription Renewals Expansion of premium reference titles Increased eBook market penetration 35+ Read & Publish Agreements Acceleration in Open Research Volu
Slide 37: Specialist Research, Powered by AI
2023 Full - Year Results 37 Specialist Research, Powered by AI
Slide 38: The Informa Group Portfolio
The Informa Group 2023 Full - Year Results 38 Portfolio Growth Investments B2B Live & On - Demand Events B2B Digital Services Academic Markets 300+ Brands, 20+ specialist markets ( Pharma, Health & Nutrition, Aviation, Beauty, Infrastructure & Construction, Luxury IIRIS (Proprietary First Party B2B
Slide 39: 2024 Growth Drivers
2024 Growth Drivers 2023 Full - Year Results 39 Growth and momentum in 2024 High single digit Revenue / Double Digit Operating Profit International Expansion Strength in the US and rapidly expanding economies in IMEA, ASEAN and China High growth B2B Markets Pharma, Healthcare, Technology, Health & N
Slide 40: Appendix
O informa Appendix
Slide 41: Faster to Zero
Faster to Zero Moving faster to become a zero waste and net zero carbon business 41 2023 Full - Year Results Continuing progress against FasterForward goals and strong recognition in external indices ESG • CarbonNeutral ® Company certification for 4th consecutive year. >80% reduction in scope 1+2* •
Slide 42: Informa Markets
Informa Markets Informa Markets is our transaction - led lie and on - demand events division. We bring specialist markets to life, helping businesses to connect, trade, innovate and grow through live experiences and digital services. 2023 2023 Revenue by vertical Revenue by region Healthcare & Pharm
Slide 43: Informa Connect
Informa Connect Informa Connect delivers content - led live and on - demand events and experiences and specialist digital content that connect audiences and help professionals to know more, do more and be more. 2023 2023 Revenue by vertical Revenue by region Finance Biotech & Life Sciences Foodservi
Slide 44: Informa Tech
Informa Tech Informa Tech focuses on the technology industry, providing B2B data and market access to customers through live and on - demand events, specialist research, specialist media brands, digital demand generation and buyer intent. 2023 2023 2023 Revenue by type Revenue by tech sub - vertical
Slide 45: Taylor & Francis
Taylor & Francis 2023 2023 2023 Taylor & Francis is a leading provider of academic research, advanced learning and open research . We work with knowledge makers around the world to ensure high - quality research has an impact, by being discovered by the right audience and contributing to human progr
Slide 46: Adjusting Items
Adjusting Items 2023 Full - Year Results 46 2023 £m 2022 £m Intangible amortisation and impairment 337.3 281.4 Acquisition and integration costs 73.0 22.0 Restructuring and reorganisation costs 11.0 (1.6) Onerous contracts and one - off costs associated with COVID - 19 - 4.7 Fair value (gain) on con
Slide 47: Currency Sensitivity
Currency Sensitivity 2023 Full - Year Results 47 Average Rates Closing Rates 2023 2022 2023 2022 GBP/USD 1.24 1.24 1.27 1.21 The anticipated impact of a 1 cent movement in the USD to GBP exchange rate in 2024: Annual revenue £17.5m Annual adjusted operating profit £7.0m Annual adjusted earnings per
Slide 48: Sponsored ADR Programme
Sponsored ADR Programme 48 Symbol IFJPY ISIN US45672B305 Ratio 1 ADR : 2 ORD Effective date 1 st July 2013 Underlying ISIN JE00B3WJHK45 Depositary Bank BNY Mellon Informa ADRs trade on the US over - the - counter (OTC) market Damon Rowan Tel: +44 20 7163 7511 E - mail: damon.rowan@bnymellon.com For
Slide 49: Additional Information and Where to Find It
Additional Information and Where to Find It In connection with the proposed transaction (the “ proposed transaction ”) between Informa and TechTarget, Toro CombineCo , Inc. (“ NewCo ” or, after the completion of the proposed transaction, “ New TechTarget ”) and TechTarget will prepare and file relev
Slide 50: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward - Looking Statements This communication contains “forward - looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Sec tion 21E of the Securities Exchange Act of 1934 that involve substantial risks and uncertainties. All statements,
Slide 51: Cautionary Note Regarding Forward-Looking Statements (continued)
Cautionary Note Regarding Forward - Looking Statements (continued) Important factors that could cause actual results to differ materially from such plans, estimates, or expectations include, a mon g others: that one or more closing conditions to the proposed transaction, including certain regulatory
Slide 52: Thank you
O informa Thank you Informa.com